US2017096679A1PendingUtilityA1
Eukaryotic expression vectors resistant to transgene silencing
Est. expiryApr 12, 2030(~3.8 yrs left)· nominal 20-yr term from priority
Inventors:James A. Williams
C12N 2820/55C12N 2840/10C12N 2710/16143C12N 15/86C12N 15/85C12N 2830/46
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to recombinant DNA molecules such as plasmids, non-viral vectors, viral vectors and hybrids thereof, and more particularly to vector modifications that improve expression of said DNA molecules in cell lines and organisms.
Claims
exact text as granted — not AI-modified1 - 13 . (canceled)
14 . An expression vector comprising a prokaryotic replication origin, a selectable marker, a eukaryotic expression cassette and tRNA promoters upstream and downstream of said eukaryotic expression cassette, said tRNA promoters each comprising the two intragenic promoter elements RNA pol III type II promoter A-box and B-box, said eukaryotic expression cassette comprising a transgene under the control of a heterologous promoter.
15 . The expression vector of claim 14 , wherein said selectable marker comprises an antibiotic free selectable marker.
16 . The expression vector of claim 14 , wherein said vector is selected from the group consisting of non-viral and viral vectors.
17 . The expression vector of claim 14 , wherein said vector is a plasmid.
18 . Vertebrate cells transfected with an expression vector, said expression vector comprising a prokaryotic replication origin, a selectable marker, a eukaryotic expression cassette and tRNA promoters upstream and downstream of said eukaryotic expression cassette, said tRNA promoters each comprising the two intragenic promoter elements RNA pol III type II promoter A-box and B-box, said eukaryotic expression cassette comprising a transgene under the control of a heterologous promoter.
19 . The vertebrate cells of claim 18 , wherein said tRNA promoters prevent gene silencing of said transgene.
20 . The vertebrate cells of claim 18 , wherein said selectable marker comprises an antibiotic free selectable marker.
21 . The vertebrate cells of claim 18 , wherein said vector is selected from the group consisting of non-viral and viral vectors.
22 . The vertebrate cells of claim 21 , wherein said vector is a plasmid.
23 . The vertebrate cells of claim 18 , wherein said vector is selected from the group consisting of non-integrating vectors and integrating vectors.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.